Scientific Articles

NGF-Inhibitors

 

Roemer FW, Guermazi A. Imaging atlas for eligibility and on-study safety of potential joint adverse events in anti-NGF studies. Osteoarthritis Cartilage 2015; 23 Suppl 1: S1-2.

 

Miller CG, Guermazi A, Roemer F. The current status of imaging in anti-NGF clinical trials. Osteoarthritis Cartilage 2015; 23 Suppl 1: S3-7.

 

Roemer FW, Hayes CW, Miller CG, Hoover K, Guermazi A. Imaging atlas for eligibility and on-study safety of potential knee adverse events in anti-NGF studies (Part 1). Osteoarthritis Cartilage 2015; 23 Suppl 1: S22-42.

 

Roemer FW, Hayes CW, Miller CG, Hoover K, Guermazi A. Imaging atlas for eligibility and on-study safety of potential hip adverse events in anti-NGF studies (Part 2). Osteoarthritis Cartilage 2015; 23 Suppl 1: S43-58.

 

Roemer FW, Hayes CW, Miller CG, Hoover K, Guermazi A. Imaging atlas for eligibility and on-study safety of potential shoulder adverse events in anti-NGF studies (Part 3). Osteoarthritis Cartilage 2015; 23 Suppl 1: S59-68.